Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
University of Nebraska
National Institutes of Health Clinical Center (CC)